Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Edison, Exelixis, Hansa, Helio, Herantis, Incyte, Indivi, Inmed, Mentari, Merck, Neurocrine, Nexalin, Novo Nordisk, One Biosciences, Ponm, Serb, Syneos, Verici Dx.